Miguel Antonio Sampedro Nunez
Overview
Explore the profile of Miguel Antonio Sampedro Nunez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parra Ramirez P, Martin Rojas-Marcos P, Paja Fano M, Gonzalez Boillos M, Peris B, Pascual-Corrales E, et al.
Endocrine
. 2023 Nov;
84(2):683-693.
PMID: 38008883
Purpose: To evaluate whether the clinical, biochemical and radiological features of patients with primary aldosteronism (PA) can predict both main subtypes of PA. Methods: A retrospective multicenter study of PA...
2.
Araujo-Castro M, Paja Fano M, Gonzalez Boillos M, Pascual-Corrales E, Garcia Cano A, Parra Ramirez P, et al.
Biomedicines
. 2023 Jul;
11(7).
PMID: 37509573
Purpose: To evaluate the diagnostic accuracy of the 131I-6β-iodomethyl-19-norcholesterol (NP-59) adrenal scintigraphy for the subtyping diagnosis of primary aldosteronism (PA), considering as gold standard for the diagnosis of unilateral PA...
3.
Araujo-Castro M, Paja Fano M, Peris B, Gonzalez Boillos M, Pascual-Corrales E, Garcia-Cano A, et al.
Endocr Connect
. 2023 Jul;
12(9).
PMID: 37410097
Purpose: The aim of this study was to evaluate the prevalence of autonomous cortisol secretion (ACS) in patients with primary aldosteronism (PA) and its implications on cardiometabolic and surgical outcomes....
4.
Araujo-Castro M, Parra Ramirez P, Martin Rojas-Marcos P, Garcia Centeno R, Gracia Gimeno P, Tome Fernandez-Ladreda M, et al.
Endocrine
. 2022 Oct;
79(2):384-391.
PMID: 36261701
Purpose: To analyze the differences in the cardiometabolic profile in patients with nonfunctioning adrenal incidentalomas (NFAI) with post-dexamethasone suppression test (DST) cortisol ≤1.4 µg/dL (NFAI ≤ 1.4) and those with...
5.
Araujo-Castro M, Parra Ramirez P, Robles Lazaro C, Garcia Centeno R, Gracia Gimeno P, Tome Fernandez-Ladreda M, et al.
J Clin Med
. 2021 Dec;
10(23).
PMID: 34884211
Purpose: To assess the risk of developing autonomous cortisol secretion (ACS) and tumour growth in non-functioning adrenal incidentalomas (NFAIs). Methods: Multicentre retrospective observational study of patients with NFAIs. ACS was...
6.
Araujo-Castro M, Parra Ramirez P, Robles Lazaro C, Garcia Centeno R, Gracia Gimeno P, Tome Fernandez-Ladreda M, et al.
Hormones (Athens)
. 2021 Jul;
20(4):735-744.
PMID: 34273083
Purpose: The aim of this study was to evaluate the diagnostic accuracy of the 1 mg dexamethasone suppression test (DST) for the prediction of autonomous cortisol secretion (ACS)-related comorbidities in...
7.
Araujo-Castro M, Robles Lazaro C, Parra Ramirez P, Hernandez M, Sampedro Nunez M, Marazuela M
Endocrine
. 2019 Sep;
66(3):650-659.
PMID: 31473918
Objective: To study the differences in the cardiometabolic profile between patients with non-functioning adrenal incidentalomas (NFAI) and incidentalomas with autonomous cortisol secretion (ACS). Methods: A total of 149 patients with...
8.
Araujo-Castro M, Sampedro Nunez M, Marazuela M
Endocrine
. 2019 Mar;
64(1):1-13.
PMID: 30847651
Adrenal incidentalomas (AI) are one of the most frequent reasons for consultation in Endocrinology, as they are present in 3-10% of the general population. Up to 20% of them may...